These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33762029)

  • 1. Bitter melon fruit extract enhances intracellular ATP production and insulin secretion from rat pancreatic
    Shimada T; Kato F; Dwijayanti DR; Nagata T; Kinoshita A; Okuyama T; Nishizawa M; Mukai E
    Br J Nutr; 2022 Feb; 127(3):377-383. PubMed ID: 33762029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
    Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH
    Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice.
    Dwijayanti DR; Shimada T; Ishii T; Okuyama T; Ikeya Y; Mukai E; Nishizawa M
    Phytother Res; 2020 Jun; 34(6):1338-1346. PubMed ID: 31845444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
    Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
    Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
    Hafizur RM; Kabir N; Chishti S
    Nat Prod Res; 2011 Feb; 25(4):353-67. PubMed ID: 21328131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.
    Han C; Hui Q; Wang Y
    Nat Prod Res; 2008; 22(13):1112-9. PubMed ID: 18855210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.
    Mahmoud MF; El Ashry FE; El Maraghy NN; Fahmy A
    Pharm Biol; 2017 Dec; 55(1):758-765. PubMed ID: 28064559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
    Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
    J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions.
    Chang CI; Cheng SY; Nurlatifah AO; Sung WW; Tu JH; Lee LL; Cheng HL
    Int J Med Sci; 2021; 18(8):1848-1856. PubMed ID: 33746602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
    Kenny O; Smyth TJ; Hewage CM; Brunton NP
    Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of superfine grinding on antidiabetic activity of bitter melon powder.
    Zhu Y; Dong Y; Qian X; Cui F; Guo Q; Zhou X; Wang Y; Zhang Y; Xiong Z
    Int J Mol Sci; 2012 Nov; 13(11):14203-18. PubMed ID: 23203059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L.
    Nkambo W; Anyama NG; Onegi B
    Afr Health Sci; 2013 Dec; 13(4):933-9. PubMed ID: 24940315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic and antihyperlipidemic activities of Forsythia suspensa (Thunb.) Vahl (fruit) in streptozotocin-induced diabetes mice.
    Zhang Y; Feng F; Chen T; Li Z; Shen QW
    J Ethnopharmacol; 2016 Nov; 192():256-263. PubMed ID: 27377336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Momordica charantia on Insulin Immune-Reactive Pancreatic Beta Cells and Blood Glucose Levels in Streptozotocin-Induced Diabetic Rats.
    Ali AM; Moqbel MS; Al-Hizab FA
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(5):438-445. PubMed ID: 36310078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract.
    Fernandes NP; Lagishetty CV; Panda VS; Naik SR
    BMC Complement Altern Med; 2007 Sep; 7():29. PubMed ID: 17892543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
    Uebanso T; Arai H; Taketani Y; Fukaya M; Yamamoto H; Mizuno A; Uryu K; Hada T; Takeda E
    J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):482-8. PubMed ID: 18202535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoglycemic effects of Siamese Momordica charantia and Phyllanthus urinaria extracts in streptozotocin-induced diabetic rats (the 1st report)].
    Higashino H; Suzuki A; Tanaka Y; Pootakham K
    Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):415-21. PubMed ID: 1464400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.